Can Remeron (mirtazapine) be weaned off safely?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Should Remeron (Mirtazapine) Be Weaned Off?

Yes, Remeron (mirtazapine) should be gradually tapered rather than abruptly discontinued to avoid withdrawal symptoms. 1

Withdrawal Symptoms from Abrupt Discontinuation

The FDA-approved drug label explicitly warns against stopping Remeron abruptly, as this can cause potentially serious withdrawal symptoms including 1:

  • Dizziness
  • Abnormal dreams
  • Agitation and anxiety
  • Fatigue and confusion
  • Headache and shaking
  • Tingling sensations
  • Nausea, vomiting, and sweating

A case report documented severe consequences of abrupt mirtazapine cessation: A patient who stopped 30 mg/day after 10 weeks developed recurrent panic attacks starting on day 2, with attacks occurring every 1-2 hours for 5 days, each lasting approximately 20 minutes. Symptoms included palpitations, dyspnea, chest pain, dizziness, nausea, and fear of dying. These attacks persisted at reduced frequency (weekly) until mirtazapine was reintroduced, after which symptoms completely resolved. 2

Recommended Tapering Approach

The general principle for antidepressant discontinuation is to taper over 10-14 days to limit withdrawal symptoms. 3 This applies to mirtazapine specifically, though the FDA label states patients should discuss tapering with their healthcare provider rather than stopping on their own. 1

For context from broader antidepressant guidelines:

  • After 9 months of treatment, dosage reduction should be used to reassess the need for continued medication 3
  • The tapering schedule should be individualized based on treatment duration and patient response
  • Even after medium-duration therapy (10 weeks), progressive tapering is advisable 2

Clinical Context for Tapering

When mirtazapine is used for specific indications, additional considerations apply:

For insomnia treatment: Mirtazapine at 7.5-30 mg has demonstrated efficacy for chronic insomnia in older adults, though 6 of 30 participants discontinued due to adverse events in one trial. 4 When discontinuing after insomnia treatment, gradual tapering remains important.

For depression: Treatment duration matters—first episodes of major depression should last at least 4 months, with recurrent depression potentially requiring prolonged treatment. 3 When discontinuing after adequate treatment duration, the 10-14 day taper guideline applies. 3

Important Caveats

  • Never stop mirtazapine without consulting your healthcare provider first 1
  • The risk of withdrawal symptoms exists even after relatively short treatment courses (10 weeks) 2
  • Patients should be educated about potential withdrawal symptoms before initiating treatment 3
  • Medication tapering and discontinuation are facilitated by cognitive behavioral therapy for insomnia when used for sleep disorders 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.